Linked Data API

Show Search Form

Search Results

1641741
star this property human indexable true more like this
star this property published true more like this
star this property registered interest false more like this
star this property answer date less than 2023-06-08more like thismore than 2023-06-08
star this property date less than 2023-06-05more like thismore than 2023-06-05
star this property date tabled less than 2023-06-05more like thismore than 2023-06-05
star this property ddp created less than 2023-06-05T21:44:23.583Zmore like thismore than 2023-06-05T21:44:23.583Z
star this property answering body
Department of Health and Social Care more like this
star this property question status Tabled more like this
star this property answering dept id 17 more like this
star this property answering dept short name Health and Social Care more like this
star this property answering dept sort name Health and Social Care more like this
star this property ddp modified
remove filter
less than 2023-06-08T16:13:12.808Zmore like thismore than 2023-06-08T16:13:12.808Z
star this property hansard heading Clinical Trials more like this
star this property house id 1 more like this
star this property identifier 187791 more like this
star this property legislature
25259
star this property pref label House of Commons more like this
star this property parliament number 58 more like this
star this property question first answered
less than 2023-06-08T15:42:54.893Zmore like thismore than 2023-06-08T15:42:54.893Z
star this property question text To ask the Secretary of State for Health and Social Care, what assessment he has made of (a) the reasons for trends in the level of patients participating in clinical trials in England since 2018 and (b) the impact of financial incentives to GPs to enrol patients in clinical trials on levels of participation; whether he has had discussions with the (i) British Medical Association and (ii) Royal College of General Practitioners on this matter; how the amount paid per patient enrolled onto a clinical trial will be calculated; and whether measures will be put in place to ensure (A) patients (1) are able to give and (2) have given fully informed consent and (B) vulnerable patients are protected. more like this
star this property session
2022/23 more like this
star this property session number 3 more like this
star this property tabling member constituency Kingston upon Hull West and Hessle more like this
star this property tabling member printed
Emma Hardy more like this
star this property title House of Commons Tabled Parliamentary Question 2022/23 187791 more like this
unstar this property type
WrittenParliamentaryQuestion
star this property uin 187791 more like this
star this property version 1 more like this
star this property written parliamentary question type NamedDay more like this
star this property answer answer
star this property creator
4645
star this property label Biography information for Emma Hardy more like this
star this property publisher
25259
star this property pref label House of Commons more like this
star this property tabling member
4645
star this property label Biography information for Emma Hardy more like this